Mixed technical signals — UnitedHealth Group consolidates near $364 as earnings approach

Traders Union
All News
Financial News
Unitedhealth group rises 0.47% today

Highlights

UnitedHealth Group shares closed at $364.31, above the MA-20 and MA-50 but below the MA-200 at $390.80, reflecting persistent long-term downtrend.
UNH reports Q3 earnings on October 28, 2025, with analysts expecting EPS of $2.81 and monitoring recent share sale by Ingalls & Snyder LLC.
Despite mixed momentum indicators and closing near today's high of $365.03, the likelihood of price increases next week is below 20%, with expected consolidation below resistance.

Earnings anticipation and insider moves drive investor sentiment

UnitedHealth Group is set to release its Q3 earnings before the market opens on October 28, 2025, with analysts expecting earnings per share of about $2.81 and projected year-over-year revenue growth. A recent share sale by Ingalls & Snyder LLC and the company’s steady dividend history with an annualized payout of $8.84 per share are also relevant corporate actions. Investors remain focused on the upcoming earnings announcement for further insight into future performance.

Mixed momentum and conflicting indicators as rally meets resistance

Momentum signals are mixed: the MACD shows strong short-term buy momentum, but the ADX suggests selling pressure is still present. RSI (53.54) and CCI readings indicate mild bullishness without overbought signals, while the Stoch RSI shows emerging selling pressure. BBP is neutral, signaling balance between buyers and sellers intraday. The Awesome Oscillator does not currently support the prevailing trend. The price is up 0.47% (+$1.71) with a narrow gap at the open, sitting near today’s high of $365.03, and showing moderate intraday volatility. There is evidence of strength toward session highs, but underlying indicators are divergent, suggesting traders are cautious despite today’s bullish performance.

Consolidation below resistance as downside risks outweigh upside

For the next week, the expected trading range is $372.57 to $377.03, with sideways movement likely. The probability of a price increase is very low (less than 20%), making further declines more likely. The baseline scenario assumes consolidation below resistance, while a bullish scenario suggests a break above $365 may target the upper range. A bearish scenario would see a fall below Ichimoku support at $354.41, signaling renewed downside risk.

Viktoras Karapetjanc, expert at Traders Union, believes UnitedHealth Group's technical picture is showing encouraging short- and medium-term momentum, though the longer-term trend still lags. He notes that consistent earnings expectations and steady dividends, even amid a recent share sale, reinforce a fundamentally resilient backdrop. Macro and sentiment signals hint at cautious optimism surrounding the upcoming Q3 results, but traders remain watchful given divergent momentum indicators. "With robust fundamentals and improving sentiment, I am constructive — if $365 is cleared, a move toward the upper range becomes more likely in the days ahead."

Previously it was noted that bullish momentum diverges from overbought signals amid increased volatility in UNH shares. The report also highlighted mixed momentum indicators and a short-term downside bias as institutional activity and earnings anticipation shaped market sentiment.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.